Human SHMT has also been recognized as a promising target for development of new chemotherapeutics due to the high demand for one-carbon units in cancer cells (Cuthbertson et al., 2021; Zarou et al., 2021; Makino et al., 2022; Situ et al., 2023). Here, SHMT2 is linked to cancer.